The burden of obesity is now well established as a precursor of cardiovascular disease and other disorders. Although better clinical guidelines exist to prevent and treat obesity, the prevalence of obesity among children and adolescents is increasing alarmingly. Primary prevention remains the gold standard to significantly reduce the public health concerns associated with obesity. Traditional cardiovascular disease risk factors (such as dyslipidemia, hypertension, type 2 diabetes) for cardiovascular disease among children and adolescents are known. The scope of this review is thus to discuss new and emerging obesity and associated-disease risk factors. Evaluation of the coronary plaque formation, diastolic dysfunction, carotid intima-media thickness and heart rate variability represent interesting tools with clinical relevance. Beyond these new cardiovascular disease risk factors, recent evidence suggests that a detrimental fetal environment, associated with for example, maternal obesity, insulin resistance, and physical inactivity, imprints fetal metabolic programming via epigenetic mechanisms that predisposes the newborn to obesity and cardiovascular disease later in life. This information may impact on the future management of maternal health, as well as for those high-risk children.
Introduction
Obesity is one of the key features of the metabolic syndrome. The latter is a constellation of cardiovascular disease (CAD) risk factors including dyslipidemia, hypertension, and hyperglycemia, a precursor of type 2 diabetes. 1, 2 Obesity has now reached an epidemic proportion not only in adults, but also in children, and especially young adults. 3, 4 For example, the obesity prevalence in the pediatric population of the United States has increased to 17% (body mass index [BMI]-for-age $ the 95th percentile on Centers for Disease Control and Prevention [CDC] growth charts) with 35% of children and adolescents being considered overweight (BMI-for-age $ the 85th percentile). The picture is not better worldwide with more than 42 million obese children. 5 Because of the burden of the obesity epidemic, 6, 7 and because its prevalence keeps growing in high-risk populations, 8 the objective of the present review is to discuss new and early evidence that outreaches our current, and more traditional understanding of lipids, blood pressure, and insulin/glucose metabolisms.
Increasing evidence suggests that obesity and its associated metabolic complications 9 have a fetal origin. 10 This intrauterine programming influence may be attributable to different maternal factors, including nutritional status, maternal weight and levels of blood lipids, glucose, and insulin. [11] [12] [13] It has been shown that the exposure to a deleterious fetal environment affects the organogenesis as well as the epigenetic profile. 14 Since obesity itself is a risk factor for pregnancy complications (gestational diabetes and pre-eclampsia), both of these early mechanisms (gestational diabetes and pre-eclampsia) have the potential to fuel the current obesity epidemic. In addition, these fetal programming factors induce cellular adaptative responses and some tissue-specific cells may be more vulnerable to these intrauterine environmental challenges. Heart rate variability, carotid intima-media thickness, left ventricular dysfunction, as well as coronary plaque formation and lipid abnormalities seen in obese children, are non-traditional cardiovascular disease risk factors and will be discussed in the present review. These non-traditional risk factors may have emerged from fetal programming factors and may represent in the future earlier cardiovascular disease markers among obese children and adolescents. The risk of long-term cardiometabolic complications among the obese pediatric population varies from one child to another. In that sense, there is a need to identify earlier non-traditional cardiovascular markers to identify higher-risk patients.
Traditional cardiovascular risk factors among children and adolescents
In the last decade, the obesity, dyslipidemic, hypertensive, and hyperinsulinemic phenotypes have been studied and well described among children and adolescents in the United States (Table 1) . 15 Pediatric obesity was defined as a BMI . the 95th percentile and those . the 85th percentile are considered at risk of being overweight. 16 Abnormal lipid profile is defined in children and adolescents by total cholesterol . 170 mg/dL (4.4 mmol/L), and/or low-density lipoprotein cholesterol (LDL-C) .110 mg/dL (2.8 mmol/L), and/or triglycerides . 150 mg/dL (1.7 mmol/L), and/or high density lipoprotein cholesterol (HDL-C) , 35 mg/dL (0.91 mmol/L). [17] [18] [19] [20] By convention, hypertension in young people is defined by a blood pressure . the 90th percentile for age, sex, and height. 21 Finally, with an increased incidence due mainly to the obesity epidemic, impaired glucose tolerance was found to be as high as 25% in obese children and adolescents. In a study of young patients with impaired glucose tolerance, half of them were found to have an increased fasting insulin level. 22 Values of reference for fasting glucose, insulin concentrations, and impaired glucose tolerance may vary upon ethnicity and were published a few years ago. 23 It is now recognized that the prevalence of these traditional cardiovascular risk factors (Table 1) increases at a very fast pace among children and adolescents. The environmental changes (physical inactivity and/or high-carbohydrates diet, for example) that took place in the last decades clearly put contemporary children and adolescents at increased risk of obesity and its related metabolic complications. However, there is a need to also determine and understand the impacts of non-traditional CAD risk factors if we want to offer better prevention programs and treatments to these children and adolescents.
The rebound of adiposity and Barker's hypothesis
More than 20 years ago, David Barker and his collaborators suggested that CAD might have a fetal origin. 24 They conducted a retrospective study among 5654 men born between 1911 and 1930 in Hertfordshire (England) and showed a strong relationship between low birth weight, as well as low weight at 1 year of age, and highest adult death rates from ischemic heart disease. 24 Later, in a landmark article, they reaffirmed their hypothesis and also discussed factors determining growth at critical periods of the fetal life, especially hormones and growth factors that might be responsible for a disproportionate fetal growth similar to that seen with undernutrition. 25 The impact of newborn growth on CAD risk profile has also been explored. The Helsinki Study analyzed 8760 people born between 1934 and 1944. Results revealed that those who were small for their gestational age at birth and thin at 2 years of age, who rapidly put on weight after 2 years, were also those who were at a highest risk for ischemic heart disease in adulthood. 10 This finding refers to the "rebound of adiposity" concept by which the rapid weight catch-up phenomenon after the age of two is associated with adult obesity, type 2 diabetes, hypertension, and cardiovascular disease. 10 Additionally, the Bogalusa Heart Study of 204 autopsies of young people aged between 2 and 39 years clearly demonstrates that artery fatty streaks and fibrous plaque associated with ischemic heart events start to develop before the age of 15 years and as soon as 2 years of age. 26 One may think that this is part of the natural process of aging, but this matter essentially points to a very early onset of the atherosclerotic process.
Barker's hypothesis as well as the Helsinki and Bogalusa studies suggest that early fetal and perinatal determinants may be responsible for adult ischemic disease. Cardiomyocytes, blood vessels, and adipocytes may be vulnerable to in utero and perinatal factors, such as malnutrition, lack of maternal physical activity, maternal hormones, and inappropriate weight. The biological mechanisms linking fetal exposure to a detrimental environment are not yet well understood. However, the epigenetic programming of key cellular functions related to energy metabolism and inflammation has been suggested as a key factor in order to understand why newborns of mothers with obesity, physical inactivity, gestational diabetes, and/or malnutrition are at a higher risk for obesity, diabetes, and CAD later in life. 27 In addition, obesity and its related metabolic complications have been shown to have a significant heritability component going up to 50% for some phenotypes such as abdominal obesity. 28 Nevertheless, although few severe obesity causative genes (leptin, leptin receptor, and melanocortin 4 receptor [MC4R]) have been identified, it is now well accepted that "common" obesity is the result of the interaction of multiple genes with the environment, each having a small effect size. 29 Altogether, gene polymorphisms only account for a small fraction of the variance of the traits suggesting that other genes and molecular mechanisms such as epigenetics remain to be identified. 30 
Epigenetics and fetal programming
Epigenetics refers to molecular mechanisms dedicated to the regulation of gene transcription. DNA methylation is the most stable and best understood epigenetic system. 31 It is usually found within the regulatory regions of most of the transcribed genes. 32, 33 DNA methylation is the addition of a methyl group (CH3) at the cytosines (Cmet) located just upstream from a guanine (CpG dinucleotides). Put simply, DNA methylation does not change the (letter) sequence (letter) of the DNA; it changes how the genetic information is interpreted.
DNA methylation has fostered considerable attention recently. It came following the demonstration that the addition or the erasure of the methyl group at CpG loci is made in response to a number of environmental stimuli such as the in utero environment. [34] [35] [36] The DNA methylation profile can also be stable over time (mitotically-stable) (some marks can be short-lived and rapidly reversed), producing long-term changes to gene expression and thus protein synthesis. 37 Since the phenotype of an individual is largely dependent on the amount of each protein composing his/her cells, tissues and organs, DNA methylation changes could therefore have profound phenotypic effects. 38 Accordingly, DNA methylation has the potential to highlight central pathophysiological processes involved in obesity, diabetes, and CAD development.
The results of a few studies have underlined the importance of epigenetics in the etiology and development of CAD risk factors. 34, 36, [39] [40] [41] [42] [43] [44] [45] Recently, we have shown that newborn DNA methylation adaptations at the leptin and adiponectin genes are associated with glucose concentrations and metabolism status during pregnancy. 14, 46 Up to 98 women were recruited at their first trimester of pregnancy and were followed until delivery. Maternal blood samples were collected at the end of each trimester of pregnancy and at delivery. At the first trimester of pregnancy, the women were slightly overweight, and generally metabolically healthy, all having a normal fasting glucose concentration. However, about a third of them were classified as having impaired glucose tolerance at the end of the second trimester of pregnancy according to the World Health Organization (WHO) guidelines. 47 At delivery, placenta and cord blood samples were collected along with the measurements of the newborn anthropometric and metabolic parameters. On average, the newborns were of normal weight at birth (3.42 ± 0.5 kg) and metabolically healthy. Briefly, we have shown that the placenta leptin gene promoter DNA methylation level was correlated with the maternal 2-hour post-oral glucose tolerance test (OGTT) glycemia.
14 As expected, the leptin gene expression levels were negatively correlated with DNA methylation levels in the placenta. This is suggestive of a functional impact of maternal hyperglycemia-associated DNA methylation changes. Very similar observations were made for adiponectin. 46 Placenta adiponectin promoter DNA methylation levels were negatively correlated with glucose levels (2 hours post-OGTT) and with the mothers' circulating adiponectin concentration at each trimester of pregnancy trimester as well as 24 hours post-delivery, suggestive of a functional impact of these epigenetic changes. Since leptin and adiponectin are two of the most potentially important adipose tissue-derived hormones regulating appetite and energy expenditure, epigenetic changes at these two gene loci, if long-lasting, have the potential to alter the energy balance regulation, and therefore, the newborn's risk to develop obesity later in life. In a ddition, we have shown that DNA methylation variability at the insulin-like growth factor 2 (IGF2) gene locus was associated with birth weight and other markers of fetal growth and development. 48 These IGF2 data emphasize the importance of this gene as an early important obesity determinant, because it is well established that birth weight and weight-gain profile in the first year of life are associated with an increased risk to develop the metabolic syndrome later in life. 10 A few other groups reported similar observations in humans, 34, 36, 49, 50 but the field clearly needs additional studies. Nevertheless, a new obesity developmental model based on fetal programming and epigenetics is emerging. 51 Other natural adaptative mechanisms are thought to imprint structural and functional changes among cardiomyocytes and tissue-specific cells (blood vessels and adipose tissue, for instance). These potential changes may predispose to CAD and are reviewed in the following sections.
Coronary plaque formation and lipid anomalies in obese children and adolescents
In 1965, Eggen et al were the first to associate the presence of coronary calcifications with significant clinical coronary lesions. 52 These coronary calcifications are also referred to as the "atherosclerotic plaque". The plaque forms progressively in arteries through different mechanisms. In particular, intracellular signaling processes are upregulated and modify the smooth muscle cells found in arteries into powerful proinflammatory cells. They later recruit cytokines, lipids, and other mediators that contribute over time to the progression and eventually rupture of the plaque. Scientists have known for decades that this atherosclerotic process starts at an early age. 26, 53, 54 Investigators from the Muscatine Heart Study 53 and others 55 have demonstrated that traditional CAD risk factors, 55 such as high triglycerides, hypertension, increased BMI, high LDL-C, as well as elevated apolipoprotein B concentrations, are all associated with the presence of atherosclerotic plaques in young asymptomatic men and women. 53, 55 This finding was found to be predictive of CAD events later in the adult life. 26 Due to a molecular defect in the HMGcoA reductase gene, familial hypercholesterolemia is a good model to study this accelerated atherosclerotic process. In this autosomal dominant condition, high levels of LDL-C accumulate in the arterial wall and prematurely stimulate the formation of severe atherosclerosis via pro-inflammation processes. However, numerous environmental factors, such as poor diet, tobacco smoking, and obesity have been demonstrated to affect the clinical expression of atherosclerosis, 56 and accelerate plaque formation even more. In the same manner, obese children and adolescents can have an accelerated atherosclerotic process in the presence of different environmental factors, but also in relation to detrimental prenatal and postnatal exposure to other factors. Clinicians should pay close attention to the familial history of dyslipidemia and the early familial history of CAD in obese children. A lipid profile should be obtained in children with significant familial history of CAD, as recommended by the American Heart Association and the American Academy of Pediatrics. 57, 58 Diastolic dysfunction associated with pediatric obesity
The Muscatine Heart Study has also revealed that excessive weight and high blood pressure were predictive of an altered left ventricular mass among children. 53, 59 Later, in a cohort of 49 healthy normal children aged 3-19 years, the presence of obesity was found to be associated with left ventricular dysfunction. 60 In 2011, Dhuper et al reported that children and adolescents characterized by obesity and hypertension had concentric cardiac hypertrophy associated with left ventricular diastolic dysfunction. 61 Evidence of cardiac remodeling in the obese adult population was prospectively demonstrated to be predictive of the later increased cardiovascular risk. 62 In addition, weight loss induced by bariatric surgery restores normal cardiac structure and function altered by the presence of severe obesity. 63 Whether left ventricular diastolic dysfunction is or is not an early predictor of the cardiovascular risk among obese children and adolescents remains to be shown prospectively in large cohorts. However, this new area of research looks promising to identify, with the use of a noninvasive method (echocardiography), higher-risk patients in the obese pediatric population.
Carotid intima-media thickness in obese children and adolescents
With such numerous hemodynamic and metabolic changes among obese children and adolescents, authors have speculated that this "domino effect" should impact on blood vessel elasticity. Since damaged carotid arteries have previously been shown to be predictive of cardiovascular outcomes, 64 some authors hypothesized that carotid intima-media thickness and stiffness found in some obese and diabetic adult patients could develop earlier in life. In this regard, 96 adolescents referred in a pediatric center for 24-hour ambulatory blood pressure monitoring, who were also obese, were found to have significantly thicker internal carotids compared to normal controls. 64, 65 Another ultrasound carotid artery study including 446 lean, obese, and type 2 diabetic youths d emonstrated that not only were the carotids of the two latter groups thicker, they were also stiffer than those of the lean control group. 66 This positive relationship between carotid intima-media thickness, and obesity or type 2 diabetes, increases with age. These data add credit to previous results obtained in the Bogalusa and the Muscatine studies. 26, 53 In retrospect, it clearly indicates that early physiological and pro-atherosclerotic changes occur in young obese and/or diabetic patients and therefore could significantly increase their risk for any cardiovascular event later in their adult life. 26 However, it is important to emphasize that not every obese child or adolescent shares the same lifetime risk of CAD. The carotid intima-media measurement in obese children and adolescents may constitute a powerful marker not only of the long-term risk of CAD, but also of morbidity and mortality.
Heart rate variability and physical capacity in obese children and adolescents
Since obesity and hypertension induce structural and metabolic changes in young individuals, it was proposed that a disturbance of the sympathetic nervous system control could also be encountered. 67 The measurement of heart rate variability was shown to be a good way to assess autonomic nervous system imbalances, cardiovascular diseases, and mortality. 68 Heart rate variability is a physiological phenomenon and a predictor of mortality in the adult population after myocardial infarction. 69, 70 It was found to be altered early in obese children. 71 The autonomic nervous system control and the physical activity of young obese individuals are modified even before puberty. 71 Recent studies have shown that fetal cardiac sympathetic activation may be influenced, in part, by pre-pregnancy maternal BMI and could represent a potential cardiovascular programming factor. 72 Again, this emerging tool may represent a non-invasive instrument to investigate obese children and adolescents at higher risk of CAD.
Conclusion
The Coronary Heart Disease Policy Model, a state-transition computer simulation used in the United States, has projected that by 2020, the present overweight phenomenon in the adolescent population will increase the prevalence of obese 35-year-old men from 30% to 37% and 34% to 44% in women. 73 By 2035, it was estimated that this projection will lead to a 5%-16% increased prevalence of cardiovascular disease, mainly caused by obesity. 73 Despite more than 30 years of primary prevention in the adult population, behavior regarding cultural beliefs, food industry, and education remain major factors against obesity prevention and management. Because obesity prevention is a complex, multi-targeted intervention and a huge challenge for public health authorities, the American Academy of Pediatrics has already published multi-approach guidelines for the management of children and adolescents with obesity. 74 Pediatric nutrition and physical activity guidelines for children have been validated but remain unknown and unfortunately underutilized. [75] [76] [77] Even, the effect of obesity summer camps has been studied and has attracted a relative interest. 78 At this point, we need to emphasize the availability and usefulness of such programs and disseminate information about them in the medical community.
The emerging novel clinical tools, such as carotid intimamedia determination by Carotid Doppler Ultrasonography in children, heart rate variability, and/or left ventricular diastolic dysfunction evaluation in obese children and adolescents, could contribute to identify higher-risk cardiovascular disease children and adolescents (Table 2 ). These high-risk patients could benefit from early identification, management, and referral to specialized multidisciplinary pediatric clinics (pediatricians, pediatric endocrinologists, pediatric cardiologists, nutritionists, and kinesiologists). In addition, to significantly reduce the obesity epidemic and its cardiovascular complications, close attention should also be also paid to prenatal and postnatal epigenetic phenomena. Emerging evidence of fetal programming shows that a broader approach should be developed to also include preventive programs targeted at pregnant women. In the future, other very interesting emerging fields, such as the microbiota, may also be considered in the individual response to anti-obesity molecules as well as potential modulators of the pro-inflammatory state seen in obese higher-risk CAD patients. 79, 80 At the present time, the growing and alarming obesity epidemic, as well as the traditional and non-traditional risk factors of CAD in children and adolescents across the world, should raise a more serious collective medical concern and urge every one of us to act now, by identifying these individuals, and to refer and treat them accordingly. 
